In recent years, diabetes has become a common chronic disease worldwide, bringing a huge threat to people's health. In order to effectively control the development of diabetes, scientists are constantly working to develop new drugs. Recently, China's first new compound hypoglycemic drug has been successfully launched, which has attracted widespread attention. So, what kind of diabetes can this new drug do?What are its advantages?
First, we need to understand the classification of diabetes
According to its pathogenesis and clinical characteristics, diabetes can be divided into two categories: type 1 diabetes and type 2 diabetes. Type 1 diabetes is caused by inadequate or complete insulin production and occurs in children and adolescents.
Type 2 diabetes, on the other hand, is caused by a combination of insulin resistance and insufficient insulin secretion, and is more common in adults. This new compound hypoglycemic drug is mainly used for type 2 diabetes.
Second, the advantages of this new drug are mainly reflected in the followingaspects
1. It is in the form of a compound preparation
That is, multiple drugs are combined together to lower blood sugar through different pathways and mechanisms. Compared with the use of a single drug, the compound preparation can more comprehensively regulate the blood sugar level of diabetic patients and improve the ** effect.
2. This new drug has a high level of safetySex and tolerability
In clinical trials, the drug has a low incidence of adverse reactions, and most of them are mildly uncomfortable, which does not have a significant impact on the quality of life of patients.
3. The drug also has a long duration
A single medication can maintain a long-term hypoglycemic effect, which is convenient for patients' medication management.
4. This new drug also has a good effect of reducing cardiovascular risk
Diabetic patients often have an increased risk of cardiovascular disease, and this new drug can effectively reduce the cardiovascular risk and improve the quality of life of patients.
3. This new type of compound lowers blood sugarThere are some other advantages to new drugs
First of all, it is simple and convenient to administer, and patients only need to take it orally according to the doctor's advice, without the need for complex injection operations.
Secondly, the new drug is relatively close to the people, and compared with other hypoglycemic drugs, it is more suitable for the affordability of the majority of diabetic patients.
In addition, this new drug also has good stability and long-term efficacy, which can continuously control patients' blood sugar levels and reduce the occurrence of complications.
Fourth, we also need to recognize thisLimitations of new combination hypoglycemic drugs
First of all, it does not completely ** diabetes, it can only play a role in controlling and alleviating the condition.
Second, this new drug is not suitable for all people with diabetes and may not be effective for some specific types of diabetes.
In addition, the use of this new drug also needs to be carried out under the guidance of the patient and cannot be abused at will.